The Board of Directors of Hangzhou Bio-Sincerity Pharma-Tech Co.,Ltd. has authorized a buyback plan on August 24, 2023.
Hangzhou Bio-Sincerity Pharma-Tech Co.,Ltd.
Equities
301096
CNE1000056N5
Biotechnology & Medical Research
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
53.88 CNY | -2.27% | -10.14% | -17.24% |
EPS Revisions
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-17.24% | 802M | |
+16.59% | 44.44B | |
+41.42% | 39.84B | |
-10.62% | 37.68B | |
+29.92% | 31.46B | |
-9.78% | 27.02B | |
+12.34% | 26.29B | |
+41.53% | 13.8B | |
+31.49% | 12.46B | |
-7.40% | 11.26B |
- Stock Market
- Equities
- 301096 Stock
- News Hangzhou Bio-Sincerity Pharma-Tech Co.,Ltd.
- Hangzhou Bio-Sincerity Pharma-Tech Co.,Ltd. authorizes a Buyback Plan.